Form 4: Anixa Biosciences Director Arnold M. Baskies Acquires 5,000 Shares

Anixa Biosciences director Arnold M. Baskies purchased 5,000 shares of common stock at $2.82 per share on January 28, 2025.

Summary

• Arnold M. Baskies, a director at Anixa Biosciences, acquired 5,000 shares of the company's common stock.
• The transaction occurred on January 28, 2025.
• The purchase price was $2.82 per share.
• Following the transaction, Mr. Baskies directly owns 120,000 shares of Anixa Biosciences common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as insider buying is generally seen as a good sign, but it's a small transaction.

Positives

• The purchase of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

Insider trading activity is closely monitored by regulators and investors as it can provide insights into management's view of the company's prospects.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
• The purchase of shares by a director is a common occurrence and is generally viewed as a positive signal.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Anixa Biosciences, insider trading, stock purchase, Form 4, director, Arnold M. Baskies, share acquisition